SCHEMBL3339892

SCHEMBL3339892

Cc1cc2nc(-c3cccc(Cl)c3)[nH]c2cc1C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 6/20 0.73
MGAM O43451 1/20 0.65
GAA P10253 1/20 0.65
SI P14410 1/20 0.65
MGAM2 Q2M2H8 1/20 0.65
NPBWR1 P48145 1/20 0.56
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TP53 P04637 2/20 0.55
MAPT P10636 2/20 0.55
HPGD P15428 2/20 0.55
MEN1 O00255 1/20 0.55
CYP3A4 P08684 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 1/20 0.55
HSD17B10 Q99714 1/20 0.55
FTO Q9C0B1 1/20 0.55
KIT P10721 1/20 0.54
AMY1A P0DUB6 3/20 0.54
SCD O00767 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3333916 0.83 GUSB (0.79) GUSBMGAMGAASIMGAM2
SCHEMBL3336441 0.83 KDM4E (0.59) GUSBMGAMGAASIMGAM2
SCHEMBL3337332 0.82 METAP2 (0.62) GUSBGAAKDM4EALDH1A1TP53
SCHEMBL7392811 0.82 GUSB (0.73) GUSBMGAMGAASIMGAM2
SCHEMBL24075313 0.80 HPSE (0.61) GUSBGAAKDM4EALDH1A1MAPT
SCHEMBL2243332 0.80 ALDH1A1 (0.67) MGAMGAASIMGAM2NPBWR1
SCHEMBL24075254 0.79 GUSB (0.50) GUSBKDM4EALDH1A1TP53MAPT
SCHEMBL28179657 0.79 HPSE (0.60) GUSBAMY1AMETAP2METAP1CBFB
SCHEMBL23447663 0.78 MEN1 (0.80) GAANPBWR1KDM4EALDH1A1TP53
SCHEMBL30014991 0.78 MEN1 (0.61) GUSBMGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198307-B2 Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2012-06-12 US disclosed
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-10 US disclosed
WO-2008140239-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145054-A1 IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME TYR, MCHR1, MCHR2 GUSB 2936/4885MGAM 3218/4885GAA 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.